Stellar Biotechnologies, Inc. 4
4 · Stellar Biotechnologies, Inc. · Filed Dec 23, 2015
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2015-12-22+10,000→ 10,000 totalExercise: $7.24Exp: 2022-12-18→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]Option grant under the 2013 Fixed Share Option Plan (the "Plan"), which shall vest as to one-third immediately, as to one-third on December 22, 2016 and as to the remaining one-third on June 22, 2017.